Effect of Exercise and Surgical Weight Loss on Polyneuropathy
- Conditions
- PolyneuropathiesObesityBariatric Surgery Candidate
- Interventions
- Other: High Intensity Interval Training (HIIT)Other: Routine ExerciseProcedure: Bariatric surgery
- Registration Number
- NCT03617185
- Lead Sponsor
- University of Michigan
- Brief Summary
The purpose of this research study is to evaluate how exercise and surgical weight loss affect how likely an individual is to develop peripheral neuropathy and other neurologic complications.
- Detailed Description
The length of this study, including screening is approximately 24 months. Patients at Bariatric Surgery Clinics will be recruited for this study. Both patients that decide to undergo bariatric surgery, and those that do not undergo surgery will be enrolled. Patients will be randomized to either a high intensity interval training (HIIT) or standard exercise regimen after eligibility is confirmed and the baseline visit is complete. All patients will complete follow-up appointments at 3 month, 12 months and 24 months. Patients that are randomized to the HIIT program will compete 2 supervised and 1 unsupervised training sessions a week for 24 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- Attending a bariatric surgery clinic
- BMI > 35 with one comorbid condition present or BMI > 40 without comorbid conditions present
- Willing and capable to sign the Institutional Review Board (IRB) approved consent form and cooperate with the medical procedures for the study duration
- Willing to accept random treatment assignment to HIIT or routine exercise counseling
- History of distal symmetric polyneuropathy (DSP) from causes other than diabetes and/or the metabolic syndrome as determined through medical history, family history, history of medications, occupational history, history of exposure to toxins, physical and neurological examinations;
- Use of warfarin, heparin, or other anticoagulants, which would increase the risk of complications from skin biopsy
- Contraindication to HIIT participation including a failed exercise stress test
- Participation in an experimental medication trial within 3 months of starting the study
- Undergoing therapy for malignant disease other than basal-cell or squamous-cell skin cancer
- Medical or psychiatric reason for not being a surgical candidate
- Requiring a walking assist device;
- Currently smoking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Bariatric Surgery/HIIT Bariatric surgery Patients who have undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week. Bariatric Surgery/HIIT High Intensity Interval Training (HIIT) Patients who have undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week. Bariatric Surgery/Routine Exercise Routine Exercise Patients who have undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months. No Bariatric Surgery/HIIT High Intensity Interval Training (HIIT) Patients who have not undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week. Bariatric Surgery/Routine Exercise Bariatric surgery Patients who have undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months. No Bariatric Surgery/Routine Exercise Routine Exercise Patients who have not undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months.
- Primary Outcome Measures
Name Time Method Change in Intraepidermal Nerve Fiber Density (IENFD) at the proximal thigh Baseline, 3 months, 12 months and 24 months As assessed by 3mm skin biopsies.Linear mixed effects regression modeling will account for multiple time points of the same measure.
- Secondary Outcome Measures
Name Time Method 24-2 Frequency Doubling Technology (FDT) Baseline, 3 month, 12 months and 24 months Retinal Fundus Photography Baseline, 3 month, 12 months and 24 months Nerve Conduction Study (NCS) Baseline and 24 months Sural, peroneal, and tibial nerves.
Utah Early Neuropathy Score Baseline, 3 month, 12 months and 24 months Scale 0-48, higher is more severe polyneuropathy
Survey of Autonomic Symptoms (SAS) Baseline, 3 month, 12 months and 24 months Corneal Confocal Microscopy (CCM) Baseline, 3 month, 12 months and 24 months Michigan Neuropathy Screening Instrument (MNSI) Baseline, 3 month, 12 months and 24 months Short Form McGill Pain Questionnaire Baseline, 3 months, 12 months, 24 months 8 Foot Get Up and Go Test Baseline, 3 months, 12 months, and 24 months Change in Intraepidermal Nerve Fiber Density (IENFD) at distal leg. Baseline, 3 months, 12 months and 24 months As assessed by 3mm skin biopsies. Linear mixed effects regression modeling will account for multiple time points of the same measure.
Cardiac Autonomic Neuropathy Testing Baseline and 24 months Valsalva- Valsalva ratio
Neuropathy Quality of Life (NeuroQOL) Baseline, 3 months, 12 months, and 24 months Modified Falls Efficacy Scale Baseline, 3 months, 12 months, and 24 months Range 0-140, higher score indicates less likely to fall
NIH Toolbox Cognitive Battery Baseline and at 24 months Incidence of polyneuropathy as defined by the Toronto definition of probable neuropathy 24 months Toronto definition of probable neuropathy-2 out of 3 of abnormal sensory examination, reflexes, and symptoms.
Modified Toronto Neuropathy Score (mTNS) Baseline, 3 month, 12 months and 24 months Range 0-33, higher is more severe polyneuropathy
Numerical Rating Scale for pain Baseline, 3 months, 12 months, 24 months Range 0-10, higher score indicates more pain
Neurothesiometer Baseline, 3 months, 12 months, and 24 months Rey Auditory Verbal Learning Test Baseline and at 24 months Diabetic Neuropathy Score (DNS) Baseline, 3 month, 12 months and 24 months Range 0-4, \>/=1 indicates polyneuropathy
Berg Balance Scale Baseline, 3 months, 12 months, and 24 months Range 0-56, higher score indicates less likely to fall
Trial Locations
- Locations (1)
University Of Michigan
🇺🇸Ann Arbor, Michigan, United States